West Pharmaceutical Services (NYSE:WST) Issues FY 2023 Earnings Guidance
West Pharmaceutical Services (NYSE:WST – Get Rating) issued an update on its FY 2023 earnings guidance on Thursday morning. The company provided EPS guidance of $7.50-$7.65 for the period, compared to the consensus EPS estimate of $7.42. The company issued revenue guidance of $2.96 billion-$2.99 billion, compared to the consensus revenue estimate of $2.96 billion. […]